2021

On July 21, 2021, New York Attorney General Letitia James announced a proposed $26 billion agreement with three drug distributors…

Recently, Abbott Laboratories agreed to pay $160 million to resolve claims that two of its units submitted false claims to…

On August 6, 2021, the Pharmaceutical Research and Manufacturers of America (PhRMA) released its updated Code on Interactions with…

On July 19, 2021, the American Society of Hematology (ASH) and 26 other organizations sent a letter to Graham McMahon, MD, MMSc,…

By Peter J. Pitts, Robert Popovian, and Wayne Winegarden What happens when regulatory ambiguity displaces sound…

On May 3, 2021, Arkansas Governor Asa Hutchinson signed HB1709 into law, which prohibits manufacturers from offering discounts on…

In mid-July 2021, the United States Food and Drug Administration (FDA) published a proposed collection of information in the…

On July 19, 2021, Oregon’s Governor, Kate Brown, signed into law Senate Bill 763 that requires pharmaceutical representatives to…

On July 13, 2021, the Centers for Medicare and Medicaid Services (CMS) released an advance copy of the calendar year (CY) 2022…

By Robert Popovian, Pharm.D., MS, and Wayne Winegarden, Ph.D. Reforms to the U.S. drug pricing environment are required, but to…